Profiling circulating DNA and RNA to identify mechanisms of therapeutic resistance and response in metastatic castration-resistant prostate cancer [ 2016 - 2019 ]

Research Grant

Researchers: A/Pr Arun Azad (Principal investigator)

Brief description Enzalutamide is a powerful hormone treatment that improves survival for men with advanced prostate cancer. Unfortunately, all prostate cancers eventually become resistant to enzalutamide and not all men initially respond to treatment. I will look for blood markers that predict which men benefit from enzalutamide treatment and try to understand how resistance to enzalutamide occurs. This may lead to more effective use of enzalutamide resulting in better outcomes in advanced prostate cancer.

Funding Amount $AUD 497,590.06

Funding Scheme Project Grants

Notes New Investigator Grant